Amadix
PrivateLast Round
Series A
Nov 5, 2025
Total Funding Raised
$31.67M
Company Overview
Amadix is a biotechnology company that develops non-invasive diagnostic tests for early cancer detection in blood.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Amadix Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Amadix Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Nov 5, 2025 | ||||
| Grant | May 19, 2025 | ||||
| Debt | Feb 10, 2025 | ||||
| Grant | Jan 16, 2022 | ||||
| Crowdfunding | Dec 1, 2021 | ||||
Series A | Nov 28, 2019 |
Key People
Founding team and executive leadership
Amadix Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| European Commission (Horizon Europe) | Grant |
| Inveready | Series A, M&A |
| Sodical Instituto Financiero de Castilla y León | Series A, M&A |
| European Commission | Grant |
| EIT Health | Grant |
| European Investment Bank Group | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2025
$1.28M grant received from EIT Health.
- Feb 10, 2025
$15.4M debt round completed.
Amadix Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Amadix's valuation, stock price, and market status.